Health status of White Americans

Oceana Canada Audit: Government’s Failure to Improve Fisheries Management Performance Continues to Cost Canada’s Wild Fish and Coastal Communities

Retrieved on: 
Tuesday, November 22, 2022
Knowledge, Fisheries and Oceans Canada, Science, Fishery, Policy, Organization, Climate change, DFO, Plastic, Indigenous peoples, Face, Integration, Canada, Health, Federation, Investment, Health status of White Americans, Aquaculture, Agriculture, Whaling

Oceana Canadas annual Fishery Audit assesses the state of Canadas fisheries and fisheries management and provides recommendations to meet federal policy commitments to return wild fish populations to abundance in Canadas oceans.

Key Points: 
  • Oceana Canadas annual Fishery Audit assesses the state of Canadas fisheries and fisheries management and provides recommendations to meet federal policy commitments to return wild fish populations to abundance in Canadas oceans.
  • Highlights from Oceana Canadas Fishery Audit for 2022 include:
    Nearly one in five wild fish stocks (17 per cent) are still critically depleted.
  • To read the full Fishery Audit, and to add your name to Oceana Canadas urgent call to rebuild Canadas fish populations, visit FisheryAudit.ca .
  • Find out more at www.oceana.ca Twitter: @OceanaCAN
    Media contacts: Angela Pinzon, Pilot PMR, [email protected] , 647-295-0517and Lesley Wilmot, Oceana Canada, [email protected] , 647-535-6326.

Chilean Healthcare NGOs Release Adaptation of Exhaustive Canadian Obesity Guidelines

Retrieved on: 
Monday, November 14, 2022
Metabolism, Surgeon, Physician, Health status of White Americans, Psychiatry, Obstetrics, Occupational therapy, Quality of life, Policy, Research, GRADE, Society, Occupational science, Obesity Canada, Guideline, University, The Society of Neurological Surgeons, Self-signed certificate, University of Toronto, Body mass index, Medicine, Obesity, Gynaecology, Chilean, Neurology, Neurosurgery

EDMONTON, Alberta, Nov. 14, 2022 (GLOBE NEWSWIRE) -- Canadas leadership in obesity care and related research is on display in Latin America today, as several healthcare associations in Chile release adult obesity treatment guidelines (CPGs) built upon CPGs published in 2020 by Obesity Canada and the Canadian Association of Bariatric Physicians and Surgeons.

Key Points: 
  • EDMONTON, Alberta, Nov. 14, 2022 (GLOBE NEWSWIRE) -- Canadas leadership in obesity care and related research is on display in Latin America today, as several healthcare associations in Chile release adult obesity treatment guidelines (CPGs) built upon CPGs published in 2020 by Obesity Canada and the Canadian Association of Bariatric Physicians and Surgeons.
  • The Chilean CPGs are the result of a pilot project launched in 2021 to assess the feasibility of adapting the Canadian adult obesity CPGs in two countries.
  • Each country used an adaptation approach based on the GRADE methodology, a systematic process for assessing peer-reviewed scientific evidence, which was used to develop the original Canadian guidelines.
  • For Canada, this project has allowed scientists and healthcare professionals to learn more about obesity care and how we can continue to update the guidelines through future collaborative research activities.

Humana Completes Aggregate $1.25 Billion Debt Offering

Retrieved on: 
Tuesday, November 22, 2022
Professional Services, Health, Hospitals, Insurance, Health Insurance, Managed Care, General Health, Sale, PNC, CMS, Marketing, Inc., Failure, Debt-to-GDP ratio, Coronavirus, News, Health status of White Americans, Government, Privacy, Form, Family, Prospectus, Star, NYSE, Information technology, Quality of life, Medicare, Information, Pharmacy, Capital market, MA, Security (finance), J.P. Morgan & Co., Vaccine, Physician, Goldman Sachs, Note, Mortality, COVID-19 vaccine, Judgement, Lifting, Medicare Advantage, Risk, Health, COVID-19 testing, History, BofA Securities, Patient, Movement, Health insurance, Risk management, Insurance, Bank, Pharmaceutical industry, Financial adviser, COVID-19, Humana

Humana Inc. (the company) (NYSE: HUM) announced today the completion of its public offering of $1.25 billion in aggregate principal amount of senior notes.

Key Points: 
  • Humana Inc. (the company) (NYSE: HUM) announced today the completion of its public offering of $1.25 billion in aggregate principal amount of senior notes.
  • The company expects net proceeds from the Senior Notes Offerings will be approximately $1.232 billion after deducting underwriters discounts and estimated offering expenses.
  • This news release includes forward-looking statements regarding Humana within the meaning of the Private Securities Litigation Reform Act of 1995.
  • The ongoing, heightened uncertainty created by the pandemic precludes any prediction as to the ultimate adverse impact to Humana of COVID-19.

MEDICURE REPORTS FINANCIAL RESULTS FOR QUARTER ENDED SEPTEMBER 30, 2022

Retrieved on: 
Thursday, November 24, 2022
TSX Venture Exchange, Sale, Marketing, Tablet, OTC, Risk, Health status of White Americans, Government, MB, Adjustment, Insurance, Pharmacy, Research, Acquisition, Depreciation, Internet, EBITDA, Growth, Legislation, Perception, United States Food Administration, Tax, Patient, Pharmaceutical industry, Video game, Bookkeeping, Health insurance, Cryptocurrency, Online shopping

Recorded total net revenue of $5.3 million during the quarter ended September 30, 2022 compared to $4.9 million for the quarter ended September 30, 2021 and;

Key Points: 
  • Recorded total net revenue of $5.3 million during the quarter ended September 30, 2022 compared to $4.9 million for the quarter ended September 30, 2021 and;
    Recorded total net revenue from the sale of AGGRASTATof $3.1 million during the quarter ended September 30, 2022 compared to $2.9 million for the quarter ended September 30, 2021 and;
    Recorded total net revenue from the sale of ZYPITAMAGof $434,000 during the quarter ended September 30, 2022 compared to $388,000 for the quarter ended September 30, 2021 and;
    Recorded total net revenue from the Marley Drugbusiness of $1.8 million during the quarter ended September 30, 2022 compared to $1.6 million for the quarter ended September 30, 2021 and;
    Adjusted earnings before interest, taxes, depreciation and amortization (EBITDA1) for the quarter ended September 30, 2022 was $1.4 million compared to adjusted EBITDA of $282,000 for the quarter ended September 30, 2021 and;
    Net income for the quarter ended September 30, 2022 was $1.1 million or $0.11 per share compared to a net loss of $946,000 or $0.09 per share for the quarter ended September 30, 2021.
  • ZYPITAMAGcontributed $434,000 of revenue for the quarter ended September 30, 2022 compared to $388,000 for the quarter ended September 30, 2021.
  • The Marley Drug business contributed $1.8 million of revenue during the quarter ended September 30, 2022 compared to $1.6 million for the quarter ended September 30, 2021.
  • Adjusted EBITDA for the three months ended September 30, 2022 was $1.4 million compared to $282,000 for the three months ended September 30, 2021.

Profusa, Inc., a Digital Health Company, Pioneering the Next Generation of Personalized Medicine, to Become a Publicly Traded Company Via Merger with NorthView Acquisition Corp

Retrieved on: 
Monday, November 7, 2022
Name, Health status of White Americans, Dressing (medical), Communication, Risk, Sale, Person, Solution, Company, Security (finance), Securities Act of 1933, Registration statement, Ownership, Attention, Incidence, Prospectus, SEC, Form, U.S. Securities and Exchange Commission, CE marking, Government, CEO, Acquisition, COVID-19, CAGR, Diabetes, Glucose, Peripheral artery disease, Combination company, Proxy, Skin, Register, Growth, Oxygen, FDA, GLOBE, Health, Sidley Austin, Intention, Technology, Failure, CA, Union, Shareholder, CGM, Mouth ulcer, Combination, Medical imaging, Pharmaceutical industry, Holding company, Phaenopsectra profusa

Upon closing of the transaction, NorthView will be renamed Profusa Inc. (the Combined Company).

Key Points: 
  • Upon closing of the transaction, NorthView will be renamed Profusa Inc. (the Combined Company).
  • Profusa is based in Emeryville, CA and is a digital health company that is pioneering the next generation of personalized medicine via the development of novel tissue-integrated biosensors.
  • Profusas technology enables continuous transmission of wireless and cloud based actionable medical-grade data for personal, professional and medical use.
  • Profusa, aDelawarecorporation, is a digital health company that is pioneering the next generation of personalized medicine as a leading developer of novel tissue integrated biosensors.

Humana Prices $1.25 Billion Debt Offering

Retrieved on: 
Tuesday, November 8, 2022
Professional Services, Health, Hospitals, Insurance, Health Insurance, Managed Care, General Health, Movement, Family, Inc., News, Judgement, Coronavirus, Physician, Phrase, CMS, Adoption, U.S. Securities and Exchange Commission, Patient, Compliance, SEC, COVID-19 testing, Form, BofA Securities, NYSE, Private Securities Litigation Reform Act, Mortality, COVID-19 vaccine, Vaccine, Population, Government, Goldman Sachs, Capital market, Privacy, Information, Medicare Advantage, Note, PNC, Star, Health status of White Americans, Debt-to-GDP ratio, MA, Prospectus, Medicare, LLC, Health, J.P. Morgan & Co., History, Lifting, Information technology, Marketing, Quality of life, Security (finance), Risk, Sale, Pharmacy, Failure, Health insurance, Public relations, Risk management, Insurance, Bank, Pharmaceutical industry, Financial adviser, COVID-19, Humana

Humana Inc. (the company) (NYSE: HUM) announced today that it has priced a public offering of $1.25 billion in aggregate principal amount of senior notes.

Key Points: 
  • Humana Inc. (the company) (NYSE: HUM) announced today that it has priced a public offering of $1.25 billion in aggregate principal amount of senior notes.
  • The company expects net proceeds from the Senior Notes Offerings will be approximately $1.232 billion after deducting underwriters discounts and estimated offering expenses.
  • This news release includes forward-looking statements regarding Humana within the meaning of the Private Securities Litigation Reform Act of 1995.
  • The ongoing, heightened uncertainty created by the pandemic precludes any prediction as to the ultimate adverse impact to Humana of COVID-19.

Worldwide Smart Home Healthcare Industry to 2029: Expansion of the Ideas of Smart Living and Smart Cities is Driving Growth

Retrieved on: 
Tuesday, November 8, 2022
Tablet, Technology, Industry, City, Google, Apple Inc., Application, General Electric Company, Privacy, Accident, Medical Guardian, Health status of White Americans, Region, LLC, Projection, Injury, Solution, Awareness, Safety, Mobile phone, Medtronic

These are some of the primary market drivers.

Key Points: 
  • These are some of the primary market drivers.
  • However, Patient health security and privacy concerns are expected to restrain the market growth.
  • Based on offering, the market is segmented into installation and repair, renovation and customization, services, and solutions.
  • The cost of healthcare is rising, and big industry participants are firmly established in North America.

Tips to Protect Your Health Data This Holiday Season

Retrieved on: 
Friday, November 4, 2022
Public health, HIPAA, Research, Awareness, PHI, Education, Address, Health Insurance Portability and Accountability Act, Campaign for Better Health Care, Fitbit, GLOBE, American Health Information Management Association, AHIMA, Health, YouTube, Airport, Travel, Consumer Reports, Advertising, Wi-Fi, Accountability Act, Privacy, Health status of White Americans, Mobile phone, Satellite navigation device, Facebook

Chicago, IL, Nov. 04, 2022 (GLOBE NEWSWIRE) -- Wearables like FitBit, smart watches, smart or connected health monitoring devices and their associated apps are popular holiday gifts that collect and store your health data.

Key Points: 
  • Chicago, IL, Nov. 04, 2022 (GLOBE NEWSWIRE) -- Wearables like FitBit, smart watches, smart or connected health monitoring devices and their associated apps are popular holiday gifts that collect and store your health data.
  • This holiday season, as part of their Better Health is in Your HandsTM campaign, the American Health Information Management Association (AHIMA) Foundation, shares tips and a new animated video that walks consumers through the steps to protect the privacy and security of health information on their personal cell phone or tablet.
  • AHIMA Foundation is a 501(c)(3) nonprofit organization and philanthropic arm of the American Health Information Management Association (AHIMA) dedicated to empowering people with health information literacy to achieve better health outcomes.
  • Recognizing that health information is human information, AHIMA Foundation works extensively to convene interdisciplinary stakeholders to identify unmet public health and education needs.

BeyonCa: A New Age of Super Premium Smart EVs

Retrieved on: 
Monday, October 31, 2022
Opus, View, Multimedia, History, GT, Solution, Electronics, Philosophy, City, Industry, Personality, Entrepreneurship, Health status of White Americans, EV, Ecosystem, Dongfeng Motor Group, Mobile phone

Weiming Soh, Founder and Chairman of BeyonCa, said: "The BeyonCa GT Opus 1 truly signifies what BeyonCa stands for, as we set out to define the super-premium smart EV segment.

Key Points: 
  • Weiming Soh, Founder and Chairman of BeyonCa, said: "The BeyonCa GT Opus 1 truly signifies what BeyonCa stands for, as we set out to define the super-premium smart EV segment.
  • The result of our team's work is the perfect combination of design, craftsmanship, comfort, sportiness, and an amazing experience."
  • Christian Klingler, Co-Founder of BeyonCa, said: "BeyonCa has a very clear idea, to define what it means to be a smart, super-premium car brand.
  • The BeyonCa GT Opus 1 exemplifies the personality of a next generation super premium EV, designed by a team with decades of experience creating super premium and luxury cars.

BeyonCa: A New Age of Super Premium Smart EVs

Retrieved on: 
Monday, October 31, 2022
Opus, History, GT, Solution, Electronics, Philosophy, City, Industry, Personality, Entrepreneurship, Health status of White Americans, EV, Ecosystem, Dongfeng Motor Group, Mobile phone

Weiming Soh, Founder and Chairman of BeyonCa, said: "The BeyonCa GT Opus 1 truly signifies what BeyonCa stands for, as we set out to define the super-premium smart EV segment.

Key Points: 
  • Weiming Soh, Founder and Chairman of BeyonCa, said: "The BeyonCa GT Opus 1 truly signifies what BeyonCa stands for, as we set out to define the super-premium smart EV segment.
  • The result of our team's work is the perfect combination of design, craftsmanship, comfort, sportiness, and an amazing experience."
  • Christian Klingler, Co-Founder of BeyonCa, said: "BeyonCa has a very clear idea, to define what it means to be a smart, super-premium car brand.
  • The BeyonCa GT Opus 1 exemplifies the personality of a next generation super premium EV, designed by a team with decades of experience creating super premium and luxury cars.